Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Tribute Pharmaceuticals Canada Inc. V.TRX

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  TBUFF

Tribute Pharmaceuticals Canada Inc is a Canadian specialty pharmaceutical company engaged in the acquisition, licensing, development and promotion of healthcare products in the Canadian and U.S. markets.
Price: $0.76 Volume: 128,866
Change: +$0.01 % Change: +1.33%
Day High/Low: 0.78/0.76 52 Week High/Low: 0.98/0.45
Last Traded: March 03, 2015 04:46 Transaction Volume: 5000
Open: 0.76 Previous Close: 0.75
Bid: 0.75 Ask: 0.76
Bid Size: 11000 Ask Size: 15000
Market Cap: 71.8m Shares Out: 94.5m
PE Ratio: N/A Dividend Yield: N/A

Latest Bullboard Posts

  • Uplisting

    0 stars

    From the cc: Look for an uplisting to the TSX in Q2 2015. Should help with recognition and an increase in investor base.

    2 stars


  • RE:Better than expected!!

    5 stars

    Yeah, I expected them to understate revenue during last month's guidance just in case they found some holes in the revenue, which they...

    2 stars


  • Better than expected!!

    5 stars

    These results are even better than I expected... Very pleased. should be a good week and should be an exceptional year for the stock...

    4.5 stars


  • RE:News

    5 stars

    These guys are starting to generate some pretty good cash now that things are picking up. In combination with the Bezalip deal on the...

    2 stars


  • News

    1.5 stars

    March 03, 2015 07:00 ET Tribute Pharmaceuticals Announces Strong 2014 Fourth Quarter and Year End Results   4th Quarter Revenue Up...

    1.5 stars